Santander's shoulder surgery will sideline him for much of the 2026 season, the Blue Jays' manager announced. This comes as a significant setback for the team, following a challenging year marred by injuries and underperformance. Santander's ongoing left shoulder issues, including a subluxation and persistent inflammation, forced him to miss the postseason and the ALCS. Now, he faces a lengthy recovery period, estimated at five to six months, under the care of Dr. Keith Meister.
The team's general manager, Ross Atkins, acknowledges the potential impact on the roster. With a limited budget for acquisitions, the Blue Jays must carefully consider their moves. Last season, they relied on their depth, with players like Ernie Clement and Addison Barger stepping up. However, the team's success in 2025 was a best-case scenario, and they now face the challenge of maintaining their offensive strength without Santander.
The absence of Santander will have a ripple effect on the team's lineup. Barger will shift to right field, opening up opportunities for Kazuma Okamoto and Leo Jiménez, who is out of options. This also means more playing time for Nathan Lukes, Myles Straw, and Davis Schneider, as well as any promising prospects. The Blue Jays are confident in their depth, but they must also consider the potential for regression in certain areas.
Atkins expresses excitement about the team's prospects, highlighting players like RJ Schreck and Joey Loperfido. However, the team faces additional challenges with the news of Shane Bieber's slower ramp-up due to forearm fatigue and Bowden Francis' season-long absence due to UCL reconstruction. These setbacks further emphasize the need for the Blue Jays to adapt and find solutions to maintain their competitive edge.
